Recommendation for adults and adolescents based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIf approved, Dupixent would be the first ...
AM EDTRecommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIf approved, Dupixent would be the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback